© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Donna Berry on the Implications of Oral Oncolytics
May 26, 2011
Donna Berry, PhD, RN
Donna Berry, PhD, RN
Donna Berry from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Implications of Oral Oncolytics
Donna Berry, PhD, RN, AOCN®, FAAN, from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the implications of oral oncolytics as observed in her research on patient adherence to oral oncolytic therapy, symptom management, patient quality of life, and patient decision making in cancer treatment.
Related Content: